3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
21
Lung Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
8
Prostatic Neoplasms
8
Stomach Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
4
Breast Neoplasms
4
Neoplasms
3
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Tongue Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
1
Interventions
Radiotherapy
5
Oxaliplatin
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
Leucovorin
4
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
sintilimab
2
pembrolizumab
2
fludarabine
2
encorafenib
2
aldesleukin
2
Tomography, X-Ray Computed
2
Specimen Handling
2
Pemetrexed
2
Magnetic Resonance Imaging
2
Irinotecan
2
Gemcitabine
2
Folfox protocol
2
Electrocardiography
2
Drug Therapy
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Docetaxel
×
30 days
×
Clear all
No trials found.